Cetera Investment Advisers
INDV icon

Cetera Investment Advisers’s Indivior Pharmaceuticals INDV Stock Holding History

Cetera Investment Advisers’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$470K Sell
11,462
-19,962
-64% -$724K ﹤0.01% 3757
2026
Q1 		$958K Buy
31,424
+383
+1% +$12.6K ﹤0.01% 2942
2025
Q4 		$1.11M Sell
31,041
-19,280
-38% -$589K ﹤0.01% 2731
2025
Q3 		$1.21M Buy
+50,321
New +$1.05M ﹤0.01% 2611

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Investment Advisers's INDV Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Indivior Pharmaceuticals (INDV) stake by 64% in Q2 2026, selling an estimated $724K and leaving 11,462 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #3757.

Cetera Investment Advisers first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.21M in Q3 2025. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Cetera Investment Advisers held 11,462 shares of Indivior Pharmaceuticals worth $470K as of Q2 2026.
  • Cetera Investment Advisers sold 19,962 Indivior Pharmaceuticals shares in Q2 2026, an estimated $724K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3757 holding.
  • Cetera Investment Advisers first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Cetera Investment Advisers's Indivior Pharmaceuticals position peaked at $1.21M in Q3 2025.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.